Platelet-derived growth factor may be a potential diagnostic and prognostic marker for cholangiocarcinoma

ISSN： 1010-4283

Source： Tumor Biology, Vol.33, Iss.5, 2012-10, pp. : 1785-1802

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Platelet-derived endothelial cell growth factor as a prognostic factor for radiotherapy outcome in patients with adenocarcinoma of the uterine cervix

By Ryu S.-Y. Oka K. Tsujii H. Suzuki Y. Nakano T.

Gynecologic Oncology, Vol. 89, Iss. 3, 2003-06 ,pp. : 414-419

Elsevier

Access to resources Recommend Favorite

Diagnostic and prognostic serum marker of cholangiocarcinoma (Review)

Oncology Letters, Vol. 9, Iss. 1, 2015-01 ,pp. : 3-8

Spandidos Publications

Access to resources Recommend Favorite

Expression and Clinical Significance of Hepatoma-Derived Growth Factor as a Prognostic Factor in Human Hilar Cholangiocarcinoma

By Liu Yan-feng

Annals of Surgical Oncology, Vol. 18, Iss. 3, 2011-03 ,pp. : 872-879

Springer Publishing Company

Access to resources Recommend Favorite

Melanoma cell-derived factor stimulation of fibroblast glycosaminoglycan synthesis-The role of platelet-derived growth factor

By Godden J.L. Edward M. MacKie R.M.

European Journal of Cancer, Vol. 35, Iss. 3, 1999-03 ,pp. : 473-480

Elsevier

Access to resources Recommend Favorite

The Effects of Platelet-Derived Growth Factor and Receptor on Normal and Neoplastic Human Ovarian Surface Epithelium

By Dabrow M.B. Francesco M.R. McBrearty F.X. Caradonna S.

Gynecologic Oncology, Vol. 71, Iss. 1, 1998-10 ,pp. : 29-37

Elsevier

Access to resources Recommend Favorite